Molecular Data Inc.
11/F, Building 15, 2177 Shenkun Road
Minhang District, Shanghai 201106
People’s Republic of China
June 21, 2021
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
|Re:||Molecular Data Inc.|
|Registration Statement on Form F-3, as amended|
|Originally filed on May 25, 2021|
|Registration No. 333-256451|
Dear Sir or Madam:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Molecular Data Inc. hereby requests the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form F-3, as amended by that Amendment No. 1 to Form F-3 filed June 11, 2021, to become effective on June 23, 2021, at 4:00 PM Eastern Time, or as soon thereafter as is practicable.
Please feel free to direct any questions or comments concerning this request to our U.S. legal counsel, Anthony W. Basch.
|By:||/s/ Steven Foo|
|Chief Executive Officer and Chief Financial Officer|